U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07389863) titled 'Evaluation of Gynecological and Sexual Sequelae' on Jan. 28.
Brief Summary: Rectal cancer accounts for approximately 40% of colorectal cancers. In France, there are 15,000 new cases per year, and the 5-year survival rate is 55% across all stages. Treatment involves surgical resection of the rectum, often combined with preoperative chemoradiotherapy and sometimes immunotherapy, depending on the tumor's immunohistochemical status.
This treatment strategy has improved recurrence-free survival but is associated with long-term functional complications affecting the digestive, urological, gynecological, and sexual systems. Surgery causes ...